"Effect of the SARS-COV-2 pandemic outbreak on the emergency department admission for an acute psychiatric condition".
Acute psychiatric condition
COVID-19
Psychiatric
SARS-CoV-2
Suicide
Journal
Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
01
01
2022
revised:
29
04
2022
accepted:
20
05
2022
pubmed:
1
6
2022
medline:
18
6
2022
entrez:
31
5
2022
Statut:
ppublish
Résumé
Preliminary evidence seems to suggest a reduction in absolute terms of Emergency Department (ED) admissions for an acute psychiatric condition during the first months of the pandemic. The study aimed to test through a long-term time analysis the effect of COVID-19 on changes in ED visits for an acute psychiatric condition. A quasi-experimental interrupted time series analysis of admissions for acute psychiatric conditions to the Emergency Department of the Merano Hospital (Italy) was performed from January 2017 to August 2021. The main outcome was the monthly rate of ED accesses for an acute psychiatric condition reported per 1000 general admissions. The pandemic outbreak was used as an intervention point. 4398 ED admissions for an acute psychiatric condition were registered. The rate of monthly admissions over total admissions increased from a mean of March 17, 1000 (SD 2.9) admissions per month in the pre-COVID-19 era to September 22, 1000 (SD 4.5) in the pandemic months, p < 0.001. In March 2020, the pandemic outbreak led to a significant increase in ED visits for an acute psychiatric condition (p = 0.013) and suicide attempts (p = 0.029), and to an increased need for pharmacological sedation in ED (p = 0.001). During the pandemic, although admissions and hospitalizations showed a non-significant decreasing trend, suicide attempts increased steadily and significantly. The outbreak of the COVID-19 pandemic caused a major increase in rates of admission to the ED for an acute psychiatric condition.
Identifiants
pubmed: 35640387
pii: S0022-3956(22)00288-6
doi: 10.1016/j.jpsychires.2022.05.035
pmc: PMC9134872
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
626-632Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Références
Brain Behav Immun. 2020 Oct;89:531-542
pubmed: 32485289
Front Psychiatry. 2021 Jul 13;12:664204
pubmed: 34326783
Am J Emerg Med. 2020 Sep;38(9):1732-1736
pubmed: 32738468
Am J Emerg Med. 2021 Oct;48:238-242
pubmed: 33991973
Front Psychiatry. 2021 Apr 23;12:563906
pubmed: 33967842
J Clin Child Adolesc Psychol. 2022 Mar 8;:1-14
pubmed: 35259031
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Lancet Psychiatry. 2021 Feb;8(2):121-129
pubmed: 33306975
Public Health. 2020 Jun;183:40-41
pubmed: 32417567
Dis Nerv Syst. 1963 Apr;24:230-3
pubmed: 13952357
Neuropsychiatr Dis Treat. 2021 Jun 03;17:1763-1778
pubmed: 34113107
BMC Public Health. 2021 Feb 8;21(1):314
pubmed: 33557816
J Psychiatr Res. 2021 Apr;136:552-559
pubmed: 33158555
West J Emerg Med. 2021 May 07;22(3):603-607
pubmed: 34125034
J Community Psychol. 2021 Aug;49(6):2134-2143
pubmed: 33635582
Psychiatry Res. 2020 Nov;293:113463
pubmed: 32977050
Front Psychiatry. 2021 Apr 06;12:643957
pubmed: 33889102
JAMA Psychiatry. 2021 Apr 1;78(4):372-379
pubmed: 33533876
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
Lancet Psychiatry. 2020 Jun;7(6):468-471
pubmed: 32330430
West J Emerg Med. 2020 Sep 24;21(6):15-23
pubmed: 33052821
Front Psychiatry. 2021 Jul 20;12:603318
pubmed: 34354606
Eur Neuropsychopharmacol. 2022 Jan;54:21-40
pubmed: 34758422
Eur Psychiatry. 2020 Apr 01;63(1):e32
pubmed: 32234102
BJPsych Open. 2022 Mar 08;8(2):e64
pubmed: 35256024
Prev Sci. 2000 Mar;1(1):31-49
pubmed: 11507793
J Psychosoc Nurs Ment Health Serv. 2005 Feb;43(2):31-7
pubmed: 15745238
Brain Sci. 2021 Oct 26;11(11):
pubmed: 34827412
Front Psychiatry. 2021 Jun 28;12:653245
pubmed: 34262488